In May 2022, Pfizer announced data from two pivotal trials of the selective sphingosine 1-phospate (S1P) receptor modulator
Semaglutide is a prescription GLP-1 receptor agonist , a class of medications that mimics the effects of the naturally occurring hormone glucagon-like peptide-1 (GLP-1)
Among the various arrhythmic outcomes, atrial fibrillation (AF), ventricular tachycardia, and atrioventricular (AV) block are common and further increase the risk of stroke, heart failure (HF), and death
Medical Weight Loss, with Tirzepatide Lake Forest, Illinois Personalized, provider-led tirzepatide treatment to help you lose weight safely, effectively, and sustainably